Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma
Background: Despite advances in therapeutics, outcomes for hepatocellular carcinoma (HCC) remain poor and there is an urgent need for efficacious systemic therapy. Unfortunately, drugs that are successful in preclinical studies often fail in the clinical setting, and we hypothesize that this is due...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
其他作者: | |
格式: | Article |
語言: | English |
出版: |
2015
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/80966 http://hdl.handle.net/10220/38996 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Nanyang Technological University |
語言: | English |